Expertise in
32
conditions

Dr. John C. Parker

Endocrinology
Wilmington Health PLLC
6781 Parker Farm Dr Ste 200, 
Wilmington, NC 
Accepting New Patients
Offers Telehealth
Referral required
Before you request
Expertise in
32
conditions
Wilmington Health PLLC
6781 Parker Farm Dr Ste 200, 
Wilmington, NC 

Overview

John Parker is an Endocrinologist practicing medicine in Wilmington, North Carolina.

Dr. Parker is highly rated in 32 conditions, according to our data. His clinical expertise encompasses Cushing's syndrome, Exogenous Cushing's syndrome, Type 1 Diabetes (T1D), and Follicular Thyroid Cancer.

He is actively involved in clinical research, co-authoring 6 peer reviewed articles and participating in 8 clinical trials. Dr. Parker is currently accepting new patients.

Specialties

Endocrinology

Licenses

Internal Medicine in NC

Hospital Affiliations

J Arthur Dosher Memorial Hospital
Novant Health New Hanover Regional Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
FirstCarolinaCare
  • HMO
  • MEDICARE MAPD
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medical Mutual
  • HMO
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
MVP Health
  • EPO
  • PPO
TeamCare
  • OTHER COMMERCIAL
Trillium
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
Trustmark
  • PPO
Tufts
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 20 Less Insurance Carriers -

Locations

Wilmington Health PLLC
6781 Parker Farm Dr Ste 200, Wilmington, NC 28405

Additional Areas of Focus

Dr. Parker has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Hypoparathyroidism
Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
Enrollment Status: Completed
Publish Date: July 08, 2026
Intervention Type: Drug
Study Drugs: Tirzepatide, Dulaglutide
Study Phase: Phase 3
A Randomized, Phase 3, Open-label Trial Comparing the Effect of the Addition of Tirzepatide Once Weekly Versus Insulin Lispro (U100) Three Times Daily in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin (SURPASS-6)
A Randomized, Phase 3, Open-label Trial Comparing the Effect of the Addition of Tirzepatide Once Weekly Versus Insulin Lispro (U100) Three Times Daily in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin (SURPASS-6)
Enrollment Status: Completed
Publish Date: November 02, 2023
Intervention Type: Drug
Study Drugs: Tirzepatide, Insulin Lispro, Insulin Glargine
Study Phase: Phase 3
A Phase 2 Study of Once-Weekly LY3437943 Compared With Placebo and Dulaglutide in Participants With Type 2 Diabetes
A Phase 2 Study of Once-Weekly LY3437943 Compared With Placebo and Dulaglutide in Participants With Type 2 Diabetes
Enrollment Status: Completed
Publish Date: July 03, 2023
Intervention Type: Drug
Study Drugs: LY3437943, Dulaglutide
Study Phase: Phase 2
A Phase 2, Randomized, Parallel, Open-Label Comparator-Controlled Trial to Evaluate the Safety and Efficacy of LY3209590 in Study Participants With Type 1 Diabetes Mellitus Previously Treated With Multiple Daily Injection Therapy
A Phase 2, Randomized, Parallel, Open-Label Comparator-Controlled Trial to Evaluate the Safety and Efficacy of LY3209590 in Study Participants With Type 1 Diabetes Mellitus Previously Treated With Multiple Daily Injection Therapy
Enrollment Status: Completed
Publish Date: October 27, 2022
Intervention Type: Drug
Study Drugs: LY3209590, Insulin Degludec
Study Phase: Phase 2
A Phase 3, Randomized, Open-Label Trial Comparing Efficacy and Safety of Tirzepatide Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Patients With Type 2 Diabetes
A Phase 3, Randomized, Open-Label Trial Comparing Efficacy and Safety of Tirzepatide Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Patients With Type 2 Diabetes
Enrollment Status: Completed
Publish Date: February 14, 2022
Intervention Type: Drug
Study Drugs: Tirzepatide, Semaglutide
Study Phase: Phase 3
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Insulin Lispro With an Open-Label Postprandial LY900014 Treatment Group, in Combination With Insulin Glargine or Insulin Degludec, in Adults With Type 1 Diabetes PRONTO-T1D
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Insulin Lispro With an Open-Label Postprandial LY900014 Treatment Group, in Combination With Insulin Glargine or Insulin Degludec, in Adults With Type 1 Diabetes PRONTO-T1D
Enrollment Status: Completed
Publish Date: May 01, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 5 Less Clinical Trials

6 Total Publications

Investigating Endogenous Hypercortisolism Prevalence in a U.S. Population With Resistant Hypertension: MOMENTUM Rationale and Design.
Investigating Endogenous Hypercortisolism Prevalence in a U.S. Population With Resistant Hypertension: MOMENTUM Rationale and Design.
Journal: JACC. Advances
Published: September 19, 2025
Similar Doctors
Expertise in
30
conditions
Dr. Ghobad Azizi
Endocrinology
Expertise in
30
conditions
Dr. Ghobad Azizi
Endocrinology
Referral required
Before you request

Wilmington Endocrinology PA

1717 Shipyard Blvd Ste 220, 
Wilmington, NC 
 (3.0 miles away)
910-254-9464
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Ghobad Azizi is an Endocrinologist practicing medicine in Wilmington, North Carolina. Dr. Azizi is highly rated in 30 conditions, according to our data. His clinical expertise encompasses Thyroid Nodule, Thyroid Cancer, Hypothyroidism, Papillary Thyroid Cancer, and Thyroidectomy. Dr. Azizi is currently accepting new patients.

Expertise in
28
conditions
Dr. Lauren F. Gratian
Endocrinology
Expertise in
28
conditions
Dr. Lauren F. Gratian
Endocrinology
Referral required
Before you request

Office

6781 Parker Farm Dr, 
Wilmington, NC 
 (2.7 miles away)
910-763-6332
Experience:
17+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Lauren Gratian is an Endocrinologist practicing medicine in Wilmington, North Carolina. She has been practicing medicine for over 17 years. Dr. Gratian is highly rated in 28 conditions, according to our data. Her clinical expertise encompasses Pituitary Tumor, Prolactinoma, Adrenal Insufficiency Pediatric, Pediatric Growth Hormone Deficiency, and Pancreaticoduodenectomy. Dr. Gratian is currently accepting new patients.

Expertise in
10
conditions
Dr. Amy E. Freeth
Endocrinology
Expertise in
10
conditions
Dr. Amy E. Freeth
Endocrinology
Referral required
Before you request

VAMC 565 Wilmington HCC

1705 Gardner Dr, 
Wilmington, NC 
 (2.8 miles away)
910-343-5300
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Amy Freeth is an Endocrinologist practicing medicine in Wilmington, North Carolina. Dr. Freeth is highly rated in 10 conditions, according to our data. Her clinical expertise encompasses Juvenile Primary Osteoporosis, Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, and Type 1 Diabetes (T1D). Dr. Freeth is currently accepting new patients.

Expertise in
23
conditions
Expertise in
23
conditions
Referral required
Before you request

Novant Health Internal Medicine Wilmington

1725 New Hanover Medical Park Dr, 
Wilmington, NC 
 (4.7 miles away)
910-662-9300
Languages Spoken:
English, Russian
See accepted insurances
Accepting New Patients
Offers Telehealth

Maya Peltsverger is an Endocrinologist practicing medicine in Wilmington, North Carolina. Dr. Peltsverger is highly rated in 23 conditions, according to our data. Her clinical expertise encompasses Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), Maturity Onset Diabetes of the Young, Autoimmune Polyglandular Syndrome Type 2, and Endoscopy. Dr. Peltsverger is board certified in Endocrinology, Diabetes And Metabolism. Dr. Peltsverger is currently accepting new patients.

Expertise in
11
conditions
Expertise in
11
conditions
Referral required
Before you request

Medical Center Pharmacy Wha

2421 Silver Stream Ln, 
Wilmington, NC 
 (5.9 miles away)
910-763-6332
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Michael Mcgarrity is an Endocrinologist practicing medicine in Wilmington, North Carolina. Dr. Mcgarrity is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), Toxic Nodular Goiter, and Hypothyroidism. Dr. Mcgarrity is currently accepting new patients.

Expertise in
6
conditions
Dr. Michael Favorito
Endocrinology
Expertise in
6
conditions
Dr. Michael Favorito
Endocrinology
Referral required
Before you request

Novant Health Pulmonary Medicine-Wilmington Annex

1500 Physicians Dr, 
Wilmington, NC 
 (5.7 miles away)
910-763-6332
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Michael Favorito is an Endocrinologist practicing medicine in Wilmington, North Carolina. Dr. Favorito is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), Obesity in Children, and Hypothyroidism. Dr. Favorito is currently accepting new patients.

Frequently Asked Questions about Dr. John C. Parker

How do I make an appointment with Dr. John C. Parker?

You can book an appointment with Dr. John C. Parker by calling their office at 910-763-6332. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. John C. Parker a top-rated expert for Cushing's syndrome?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. John C. Parker is classified as an Distinguished expert for Cushing's syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. John C. Parker specialize in?

While Dr. John C. Parker is a Endocrinology, they have specific expertise in Cushing's syndrome, Exogenous Cushing's syndrome, and Type 1 Diabetes (T1D). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Endocrinology.

Does Dr. John C. Parker participate in research or clinical trials?

Yes. Dr. John C. Parker has published 6 articles and abstracts on conditions like Cushing's syndrome. You can view a list of Dr. John C. Parker's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. John C. Parker accept my insurance?

Dr. John C. Parker accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 910-763-6332 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Parker's expertise for a condition
ConditionClose
    View All 27 Advanced Conditions
    View All 35 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile